Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Return on Assets (2016 - 2025)

CytomX Therapeutics' Return on Assets history spans 11 years, with the latest figure at 0.11% for Q4 2025.

  • For Q4 2025, Return on Assets fell 36.0% year-over-year to 0.11%; the TTM value through Dec 2025 reached 0.11%, down 36.0%, while the annual FY2025 figure was 0.13%, 33.0% down from the prior year.
  • Return on Assets reached 0.11% in Q4 2025 per CTMX's latest filing, down from 0.17% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.38% in Q1 2025 to a low of 0.52% in Q3 2022.
  • Average Return on Assets over 5 years is 0.11%, with a median of 0.15% recorded in 2023.
  • Peak YoY movement for Return on Assets: soared 47bps in 2023, then plummeted -36bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.33% in 2021, then fell by -25bps to 0.41% in 2022, then surged by 99bps to 0.0% in 2023, then soared by 9228bps to 0.25% in 2024, then plummeted by -146bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for CTMX's Return on Assets are 0.11% (Q4 2025), 0.17% (Q3 2025), and 0.35% (Q2 2025).